Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00601003
Title Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Giselle Sholler
Age Groups: adult | child
Covered Countries USA

No variant requirements are available.